What is the recommended treatment approach for a patient with pterygium?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pterygium Treatment

Surgery is the definitive treatment for pterygium, with excision plus conjunctival autograft being the gold standard technique to minimize recurrence. 1, 2

Indications for Surgical Intervention

Surgical removal is indicated when pterygium causes:

  • Visual impairment from extension onto the optical zone 1, 3
  • Significant corneal astigmatism 1, 3
  • Persistent ocular irritation despite conservative measures 3
  • Cosmetic concerns affecting quality of life 1

Optimal Surgical Technique

The preferred surgical approach is pterygium excision with conjunctival autograft (CAU), which provides superior outcomes compared to other techniques. 2, 4

Technical Considerations:

  • CAU is superior to amniotic membrane transplantation for both primary and recurrent pterygium 2, 4
  • Rotational conjunctival flap offers shorter surgical time and prevents graft displacement due to its vascular pedicle 4
  • Ensure adequate conjunctival graft size to prevent postoperative retraction 2
  • Use thin conjunctival grafts with minimal Tenon tissue 2
  • Fibrin glue reduces recurrence rates compared to sutures 2
  • Amniotic membrane should be reserved for cases with large conjunctival defects or insufficient conjunctiva 4

Adjunctive Therapy to Prevent Recurrence

Mitomycin C (MMC) at 0.02% concentration applied for 15 seconds during surgery is the recommended adjuvant to prevent recurrence. 5, 2

Alternative Adjuvants:

  • Topical cyclosporine combined with conjunctival autograft shows the best evidence for reducing recurrence 6
  • Subconjunctival 5-fluorouracil (5-FU) injections are safe and effective for halting progression 2
  • Anti-VEGF agents (bevacizumab) show temporary benefit but effects are not sustained 2
  • Beta-irradiation can be used but carries risk of adverse effects 6, 3

Anesthesia Selection

Use topical anesthesia rather than retrobulbar anesthesia to reduce the risk of postoperative diplopia. 5

Critical Surgical Complications to Avoid

Ocular Motility Complications:

  • Diplopia from medial rectus muscle damage or scarring 7, 5
  • Exotropia from medial rectus damage 7, 5
  • Esotropic restrictive strabismus from scarring 7, 5
  • Ocular motility problems from florid scarring in recurrent cases 7, 5

Prevention Strategies:

  • Meticulous surgical technique to avoid medial rectus injury 5
  • Minimize excessive suturing 2
  • Ensure adequate graft coverage without tension 2

Management of Recurrent Pterygium

For recurrent pterygium, perform excision with conjunctival autograft plus MMC as adjuvant therapy. 2

Non-Surgical Options for Early Recurrence:

  • Multiple weekly subconjunctival 5-FU injections to halt progression 2
  • Repeated anti-VEGF injections for impending recurrence (temporary effect) 2

Risk Factors for Recurrence

Patient-related factors:

  • Dry eye disease 2
  • Black race 2
  • Young age 2
  • Fleshy appearance of pterygium (controversial) 2

Surgical factors to avoid:

  • Excessive suturing 2
  • Insufficient conjunctival graft size 2
  • Thick conjunctival graft with retained Tenon tissue 2
  • Postoperative graft retraction 2

Timing of Recurrence

Most recurrences occur within the first 3-6 months postoperatively, though late recurrence can occur years later. 2

References

Research

Update on overview of pterygium and its surgical management.

Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2022

Research

Recurrent Pterygium: A Review.

Journal of current ophthalmology, 2021

Research

[Pterygium: etiology, pathogenesis, treatment].

Vestnik oftalmologii, 2017

Research

How to minimize pterygium recurrence rates: clinical perspectives.

Clinical ophthalmology (Auckland, N.Z.), 2018

Guideline

Treatment of Pterygium with Adjunctive Therapies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pterygium: new insights.

Eye (London, England), 2020

Guideline

Surgical Treatment of Pterygium

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the management of pterygium?
What are the recommended eye drops for managing pterygium?
What are the treatment options for pterygium?
What is the medical term for a skin-colored tissue growth around the pupils of the eyes?
What are the treatment options for pterygium?
What are the contraindications for Nasogastric (NG) tube placement?
What is the recommended first-line eradication therapy regimen and dose for a patient with a confirmed diagnosis of Helicobacter pylori infection, considering their past medical history and potential antibiotic allergies?
Is a conservative approach with over-the-counter (OTC) pain medication, such as acetaminophen or ibuprofen (nonsteroidal anti-inflammatory drug (NSAID)), and rest, ice, and elevation (RICE) sufficient for a 20-year-old patient with hand pain following an injury and a normal x-ray, with no significant medical history?
What is the possible diagnosis and next steps for a 43-year-old female patient with a 2-month history of bilateral wrist and finger pain, exacerbated by typing, with a past medical history of diabetes (on Metformin), hyperlipidemia (on Atorvastatin), fatty liver, and hypertension (on Losartan), who presents with elevated ESR, positive Phalen's test, Tinnel's sign, and Durkan's test, and has recently been treated with Fosfomycin for urinary symptoms?
What is the best approach for a patient with frequent anxiety, currently taking alprazolam (Xanax) 0.5mg as needed, every day, to switch to lorazepam (Ativan)?
What are the treatment options for a patient experiencing blurry vision?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.